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Abstract
Purpose: The widespread coronavirus disease 2019 (COVID-19) pandemic has resulted in signiﬁcant changes in care delivery among
radiation oncology practices and has demanded the rapid incorporation of telehealth. However, the impact of a large-scale transition to
telehealth in radiation oncology on patient access to care and the viability of care delivery are largely unknown. In this manuscript, we
review our implementation and report data on patient access to care and billing implications. Because telehealth is likely to continue after
COVID-19, we propose a radiation oncologyespeciﬁc algorithm for telehealth.
Methods and Materials: In March 2020, our department began to use telehealth for all new consults, posttreatment encounters, and followup appointments. Billable encounters from January to April 2020 were reviewed and categorized into 1 of the following visit types: inperson, telephonic, or 2-way audio-video. Logistic regression models tested whether visit type differed by patient age, income, or provider.
Results: There was a 35% decrease in billable activity from January to April. In-person visits decreased from 100% to 21%. Sixty percent of
telehealth appointments in April were performed with 2-way audio-video and 40% by telephone only. In-person consultation visits were
associated with higher billing codes compared with 2-way audio-video telehealth visits (P < .01). No difference was seen for follow-up
visits. Univariate and multivariable analysis identiﬁed that older patient age was associated with reduced likelihood of 2-way audiovideo encounters (P < .01). The physician conducting the telehealth appointment was also associated with the type of visit (P < .01).
Patient income was not associated with the type of telehealth visit.
Conclusions: Since the onset of the COVID-19 pandemic, we have been able to move the majority of patient visits to telehealth but have
observed inconsistent utilization of the audio-video telehealth platform. We present guidelines and quality metrics for incorporating
telehealth into radiation oncology practice, based on type of encounter and disease subsite.
Ó 2020 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Since its initial onset at the end of 2019, severe acute
respiratory syndrome coronavirus 2 has caused a
pandemic that has transformed health care across the
continuum. The widespread coronavirus disease 2019
(COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 has resulted in rapid and signiﬁcant change

https://doi.org/10.1016/j.adro.2020.09.015
2452-1094/Ó 2020 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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in care delivery among radiation oncology practices
everywhere. Our health system, located in the New York
City metropolitan area, is within the epicenter of the
COVID-19 outbreak. We alone have diagnosed over
40,000 patients with COVID-19, managed 14,000 hospitalized patients, and discharged over 10,000 of those
cases.1 The health system's crisis management program
implemented a comprehensive action plan on March 13,
2020, with multiple policies designed to protect staff and
manage the surge in patient volume. As the volume of
COVID-19epositive patients started to overwhelm the
health system, policies implemented in radiation medicine
allowed for safe, high-quality medical care to continue
throughout our multiple locations.2,3 In May 2020,
although new COVID-19 cases have decreased in New
York, it is apparent that health care has changed permanently. New approaches to care, including telehealth,
were adopted during this period and will redeﬁne how
health care is provided worldwide.
Telehealth, as deﬁned by the Ofﬁce for the Advancement of Telehealth, comprises the use of telecommunications and information technologies to share information
and to provide clinical care, education, public health, and
administrative services at a distance.4 Technological improvements have made synchronous telehealth more
feasible, deﬁned as the delivery of a live, interactive video
connection that transmits information in both directions
during the same period.5 Before COVID-19, widespread
adoption was slow owing to barriers including limited
reimbursement, regulatory restrictions, privacy issues, and
lack of patient and provider comfort and preference.6,7
However, this abruptly changed with the onset of the
COVID-19 pandemic.
The COVID-19 crisis created an acute transition to
telehealth to maintain safe operations for patients and
health care providers alike. The US government relaxed
the regulatory requirements for telehealth, and the Center
for Medicare and Medicaid Services (CMS) greatly
expanded ﬁnancial coverage, paving the way for private
insurers to follow suit.8 The simultaneous removal of
these 2 signiﬁcant barriers, coupled with the availability
of various telehealth platforms already in the market and
the government's decision to waive the requirement to use
Health Insurance Portability and Accountability Act
(HIPAA)-compliant communication platforms, catalyzed
telehealth's widespread adoption into the clinic setting.9
Although the reimbursement parity enacted by CMS
and private payers was initially limited to the duration of
the COVID-19 pandemic response, CMS has said widespread use of telehealth is likely to continue in postpandemic care.10
For telehealth to continue, it must enhance patient
access and outcomes, clinical efﬁciency, or both. In
pursuing these goals, there is much to learn regarding the
effective use of telehealth in radiation oncology. Poor
implementation and execution of telehealth pose
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potential risks to the patient owing to the complexity of
cancer care and the nuances involved with radiation
therapy. Telehealth practice carries the risk of exacerbating disparities of patient access to care for those who
do not have access to high-speed Internet or video calling.11 Furthermore, continued widespread use of telehealth depends on identifying feasible business models
for its use. We must recognize that the rapid adoption of
this technology in radiation oncology during COVID-19
has been done with limited data, and we must be careful
of unintended consequences.12 Currently, there are no
guidelines for optimal and appropriate use of telehealth
in radiation oncology, and no quality metrics have been
established.
In our academic multisite radiation oncology department, we rapidly implemented telehealth as the COVID19 pandemic unfolded. In this manuscript, we review our
implementation process, outline lessons learned about
patient access and billing, and use these data to propose a
radiation oncologyespeciﬁc algorithm for moving forward with telehealth.

Methods and Materials
Our department consists of 7 outpatient radiation
oncology facilities with 20 full-time faculty spread
throughout the New York metropolitan area. Before
March 2020, we exclusively saw patients in person. Our
health system had deployed a telehealth strategy over the
preceding 3 years but only on a trial basis. As COVID-19
crisis management planning took hold in mid-March
2020, our department began preparing for full implementation of telehealth. A HIPAA-compliant platform,
Amwell Telehealth (American Well Corporation, Boston
MA), was selected to deliver telehealth care. This platform was purchased by our health system for use
throughout all outpatient sites before the pandemic. We
promptly purchased the necessary equipment and began
credentialing physicians for a 2-way audio-video software package. Simultaneously, we trained our secretarial
and billing teams to be integrated into the department's
telehealth workﬂow process. Secretarial teams were
asked to schedule patients for telehealth visits and assist
them in accessing the platform. Midlevel providers and
resident trainees were also trained and incorporated into
the telehealth workﬂow. In general, midlevel providers
and residents would initiate telehealth encounters and
troubleshoot any technical difﬁculties with patients.
Upon completion of their assigned clinical tasks, the
encounter would be transferred to the attending physician. By March 28, 2020, all providers had been
credentialed and provided guidance to use telehealth in
their practices. Our initial roll-out was to use telehealth
for all new consults, posttreatment encounters, and
follow-up appointments. Telehealth was to be conducted
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Figure 1 The number of billable consult and follow-up appointments by method of encounter (in-person vs telephonic vs 2-way
audio-video). In-person visits became a small portion of our care in April. In April, telephonic-only visits increased compared with
2-way audio-video and in-person visits.

with a 2-way audio-video platform, with telephone-only
appointments reserved for situations in which 2-way
audio-video was not feasible. In-person on-treatment
visits (OTVs) continued as per our usual prepandemic
workﬂow.
Billable encounters, representing consultation and
follow-up appointments, from 6 of our radiation oncology
ofﬁces between January 1 and May 1, 2020, were available for review in our HIPAA-compliant administrative
database. Each encounter was categorized into 1 of the
following visit types: in-person, telephonic, or 2-way
audio-video. The patient's zip code and provider name
were recorded. Patient income was estimated by using
data from the 2018 census that estimates median income
by zip code. Age was calculated at date of encounter
(available at 4 of the 6 facilities).
SPSS was used for statistical calculations. The association between type of telehealth visit and charged level
of visit was calculated using the independent sample t
test. Logistic regression tested differences in visit type by
patient characteristics including age, income, and provider. All tests were 2-sided and were considered to be
statistically signiﬁcant at P < .05. Analyses were conducted using SPSS (SPSS, Chicago, IL).

80%
70%
60%
50%
40%
30%
20%
10%
0%

2 Way AV

Between January 1 and May 1, 2020, 2997 billable
evaluation and management encounters occurred (Fig 1).
Overall, there was a 35% decrease in billable activity
from January to April. In-person visits represented 100%
of visits in January and February, 90% of visits in March,
and 21% of visits in April. Sixty percent of telehealth
appointments in April were performed with 2-way audiovideo and 40% by telephone only. Since the initiation of
our telehealth program, there has been a steady increase in
telephone-only encounters (P < .01).
For patients using telehealth, the median age was 71
years (range, 22-93 years). Median income by zip code
was $88,815 (range, $26,239-$168,902). We reviewed
clinical and demographic variables to assess the likelihood to complete a 2-way audio-video versus telephoneonly appointment (Fig 2). Univariate analysis identiﬁed
that older patient age by year (P < .01; odds ratio, 0.97)
was associated with reduced likelihood of 2-way audiovideo encounters. The physician conducting the appointment was also associated with the type of telehealth
appointment selected (P < .01), and the percentage of
2-way audio-video usage varied from 22% to 100%.
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Figure 2 Factors affecting the type of telehealth visit that was conducted (2-way audio-video vs telephonic only). Median income was
not associated with type of telehealth visit (P Z .48). Older age was associated with increased telephonic-only visit (P < .01).
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Patient income was not associated with the type of telehealth visit (P Z .48). On multivariable analysis, when
controlling for median income, physician, and age, the
physician conducting the visit (P < .01) and older patient
age (P Z .01; odds ratio, 0.97) continued to be associated
with lower usage of telehealth appointments.
In-person visits can be billed based on both time and
complexity whereas 2-way audio-video encounters are
billed only based on time. We identiﬁed that for consultations, in-person visits were associated with higher
billing codes compared with 2-way audio-video encounters (P < .01). No difference was seen for follow-up visits
(P Z .36, Fig 3).

Discussion
The COVID-19 pandemic has resulted in the immediate initiation of telehealth for evaluation and management visits in our radiation oncology department. We
were able to successfully move the majority of visits to
telehealth while permitting the option of in-person appointments for those who could not participate in telehealth. This rapid implementation allowed us to continue
providing patients with access to radiation oncology
physicians while reducing patient exposures from travel
and in-ofﬁce visits. Our results support the continued use
of telehealth after the pandemic, but whether it should be
used for only speciﬁc patients or types of visits remains to
be determined.

Challenges of rapidly implementing 2-way audiovideo telehealth
We observed inconsistent utilization of the audio-video
telehealth platform and increased use of backup telephonic visits over time. To improve the use of telehealth
going forward, it is crucial to understand why this was the
case. Although the various platforms for telehealth have
been in place for some time, many of the factors needed to

establish a successful interface remain less than ideal.
Successful implementation of telehealth requires (1)
appropriate access to the correct technology (smartphone
or computer with appropriate high-speed Internet access)
and (2) understanding of and comfort in using the technology. Our suggested workﬂow during the initial
incorporation of telehealth was for our administrative staff
to provide instructions to the patient on how to use the
telehealth platform at the time of scheduling. They would
also record the phone number and/or email that would be
used for the telehealth appointment. If the patient stated
that they were unable to access the telehealth platform due
to technological limitations, they were scheduled for a
telephonic visit or, if preferred, an in-person visit. Clinicians were responsible at the time of the scheduled
appointment for sending a web link for the appointment
based on the information recorded by the administrative
staff and for addressing any technical difﬁculties that may
occur.
Our experience found that older patients were less
likely to navigate 2-way audio-video encounters. With
the hypothesis that this may be due to less comfort with
the technology, we will be asking administrative staff to
call all patients the day before their visit to perform a test
visit. Alternatively, if additional training and assistance
do not help them use this technology, it may be that some
older patients may not be suitable to be assessed via
telehealth. Regardless of age, it is unclear why we saw
reduced use of audiovisual and increased use of telephone
visits over time. We expect that the platform interfaces
will continue to improve with easier access for patients
and that patients will become more familiar with the
technology and embrace telehealth for their medical care.
However, we do recognize that certain patients simply
prefer in-person visits and may represent the subgroup
that has had difﬁculty navigating a 2-way audio-video
encounter. As we move forward from the pandemic, we
will be expanding in-person appointments, giving patients the opportunity to select the type of visit most
appropriate for them.
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Figure 3 The effect of 2-way audio-video telehealth on level of visit charges. The level of appointment charged for telehealth appointments was not different for follow-up appointments (P Z .36). For consultation appointments, patients were more frequently billed
a lower level of visit than for an in-person visit (P < .01).
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In addition to patient-speciﬁc factors, we found that
physician preference (adopters vs nonadopters) independently predicted the method of telehealth encounter. We
plan to revisit the physician training process, which may
help modify provider behavior and improve utilization of
2-way audio-video telehealth. Given the issues associated
with the audio-video platform, we were pleased that on
April 30, 2020, CMS extended payment of telehealth to
include telephonic visits. Nevertheless, we continue to
recommend 2-way audio-video encounters as the standard
of telehealth care to the extent possible; we believe the
video aspect of the visit is a very valuable component of
being able to offer appropriate clinical advice and establish a patient-physician relationship.
We found that the average level of visit charged for
telehealth consultations using the 2-way audio-video
telehealth encounter was lower than that charged for inperson visits. Our data show that >90% of new consultations done in-person are typically charged as a level 4 or
5 visit compared with only approximately 60% of new
consultations seen using 2-way audio-video telehealth.
Among other reasons, the lower levels of visit charges are
likely reﬂective of telehealth visits being shorter in
duration than in-person visits and the lack of a comprehensive physical examination being performed. Although
we expect that with experience and training, providers
will be able to learn more effective ways to perform better
physical examinations via telehealth, some level of
discrepancy between charge levels will likely persist between these types of visits. Based on evaluation and
management Medicare fee schedule, our data suggest that
this difference translates to an approximately 11%
decrease in revenue per new visit. The average difference
will be greater with increased use of telephonic-only
visits. This may be important for some practices to
consider. In our experience, many of the patients seen for
initial consultation with telehealth required an in-person
visit for further education and physical examination
before simulation and were charged for a 15-minute inperson follow-up visit, reducing the deﬁcit seen from the
consultation charges.
For telehealth to continue as a successful model of care
delivery, it must improve patient access to care, patient
outcomes, and care efﬁciency, and ideally it could improve
all of these metrics. Given current billing limitations for
telehealth, our data show that reliance on telehealth for all
care may not be ﬁnancially sustainable for clinics to
implement. It is also not likely to be appropriate for every
clinical encounter. Although telehealth was rapidly adopted into our radiation oncology department, the limited
literature and overall experience within our discipline
mandate that we carefully examine implementation and
outcomes.13 We convened a department task force to
deﬁne the optimal use of telehealth and created guidelines
for incorporating telehealth for future evaluation and
management visits (Table 1). We created separate
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recommendations based on type of encounter (new
consultation, on-treatment visit, posttreatment encounter,
follow-up visit). Workﬂows for new consultation appointments are described in Figure 4. Follow-up recommendations were based on the disease subsite and
perceived suitability for telehealth (Table 2). We recognize
that the transition to telehealth must be done in tandem
with the collection of data on quality measures. The National Quality Forum suggested 4 domains that may be
used as a framework for measuring the effectiveness of
telehealth: access to care, ﬁnancial impact/cost, experience,
and effectiveness. As such, we propose quality measures
applicable to radiation oncology using this framework to
measure implementation and outcomes (Table 3).

Framework for incorporating telehealth into
consultation visits
We see signiﬁcant opportunities in incorporating telehealth for consultation visits (Fig 3). Telehealth approaches can include telehealth consults through audiovideo platforms or telephonic consults supplemented by
in-ofﬁce follow-up where needed (eg, for older patients
who cannot access or use audio-video platforms). Radiation oncology is uniquely amenable to telehealth because
most of the diagnostic workup is often completed before
the consultation, and simulation requires patients to travel
on-site, thereby giving the clinician a built-in opportunity
to meet the patient in-person before the initiation of
treatment.
A potential beneﬁt to incorporating telehealth into the
consult workﬂow includes the ease of scheduling,
particularly for vulnerable and elderly populations that are
dependent on caregivers.14 An Australian study showed
that 52% of patients reported concern regarding treatment
delays in at least 1 treatment phase of their oncology care,
including 31% who expressed concern regarding the time
interval between deciding to have radiation therapy and
commencement of radiation therapy.15 Shorter time from
diagnosis to treatment improves patient outcomes,16 reduces patient anxiety,15 and improves patients' satisfaction and their perception of the quality of care.17
Telehealth removes many of the logistical barriers
required to schedule appointments, and we anticipate that
it will shorten the interval from referral to consult and
expedite scheduling for treatments. The beneﬁt of faster
appointment times has been seen in other disciplines; a
notable example is the Veterans Affairs liver transplant
experience, in which the use of telehealth resulted in a
substantial reduction in time from referral to initial evaluation and placement on the liver transplant waitlist.18 We
believe that similar beneﬁts will be seen in oncology
patients in all geographic areas.
We recognize that telehealth can be disruptive and that,
in some disease sites, the inability to perform an in-person
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Table 1
Visit type
Consult

OTVs

Posttreatment
evaluation

Follow-up

Table 2 Recommendations regarding appropriateness of
telehealth for follow-up care with minimum number of inperson examinations

Telehealth recommendations by type of encounter
Recommendations
Patient have option of booking their initial
consult via 2-way audio-video telehealth
(see Fig 3)
Coordinate in-person follow-up or physical
examination with simulation
Telephonic-only consult is discouraged
OTVs should continue in person
Telehealth can be used as a secondary tool
to provide additional clinical care
Patient have option of booking PTE via
telehealth, except for head and neck,
gynecologic, and anal cancer
In-person examinations can be scheduled
after telehealth as clinically indicated
Multidisciplinary team discussion to
coordinate telehealth visits to reduce
duplicated physical examinations and
visits
Recommendations are made based on
disease subsite, incorporating NCCN
recommendations for follow-up and in
consideration of (1) the necessity of a
physical examination ﬁnding to assess
treatment response and (2) requirement
of an in-person physical examination for
cancer surveillance (see Table 2)

Appropriateness Disease site

Minimum
site-speciﬁc
in-person
examinations

High

Year 1-2: 1 to 2
examinations
annually
Year 3-5: as
clinically
indicated

CNS
Breast
Lung
GI (except
anal cancer)
GU/prostate
Soft tissue
sarcoma
Skin
GI/anal cancer
(after complete
response)
Lymphoma

Moderate

Low

Head and neck
cancer Gynendometrial
Gyn-cervical

Year 1-2: 2
examinations
annually
Year 3-5:
annual
examination
Year 1-2:
every 3-6
months
Year 3-5:
every 6-12
months

Abbreviations: NCCN Z National Comprehensive Cancer Network;
OTV Z on-treatment visits; PTE Z posttreatment encounters.

Abbreviations: CNS Z central nervous system; GI Z gastrointestinal; GU Z genitourinary; Gyn Z gynecologic.

physical examination may make it difﬁcult for the provider to offer a comprehensive recommendation. For
these disease sites, we think it is reasonable to consider
the consultation appointment as an opportunity to triage
the patient while maintaining the beneﬁts of early access,
convenience, and early care coordination. An in-person
visit can be scheduled immediately before simulation to
allow for a more detailed examination. This system can

also facilitate telehealth-based care for patients with
certain difﬁculties (eg, signiﬁcant cognitive or communication impairment) that necessitate in-person evaluation. We do believe that with training and innovation,
certain aspects of the physical examination can become
more accessible to telehealth, especially with devices that
link through the virtual visit. As an example, multiple
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Physical exam on day
of simulaon

Simulaon

Figure 4

Framework for incorporating telehealth into consult workﬂow.

No
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Table 3
metrics

Radiation oncologyespeciﬁc telehealth quality

Domain
Access to care

Financial impact

User experience

Clinical
effectiveness

Measures
Time from referral to consult
Time from consult to simulation
Access to care for underserved patients
Simulation cancellation rate
Cost of telehealth implementation and
maintenance
Number of second opinion consults
Difference in reimbursement
Cost savings to patients e direct and
indirect
Cost savings from care coordination
Patient satisfaction
Provider satisfaction
Time required for technical
troubleshooting
Documentation of pain or KPS
Rate of unexpected hospital admissions
Effectiveness in coordination and
shared care
Patient adherence to recommended
follow-up schedule
Clinical outcomes

Abbreviation: KPS Z Karnofsky Performance Status.

online resources exist to guide providers in how to
conduct a neurologic examination using 2-way audiovideo conferencing.19,20

Framework for incorporating telehealth into ontreatment and follow-up care
Posttreatment, we recommend including telehealth as
part of routine follow-up care as early as safely possible.
Telehealth permits discussion of laboratory and imaging
results, as well as side effect management. Any concerning ﬁndings during a telehealth visit should always
prompt an in-person visit. Certain cancer subsites are
more dependent on in-person physical examinations for
assessment of treatment response and surveillance; these
considerations are built into our cancer siteespeciﬁc
recommendations. For all disease sites, telehealth should
always be used to prevent duplicated clinic visits and
examinations by different providers in the multidisciplinary team.
We continue to recommend in-person weekly OTVs.
Because patients must travel to the radiation oncology
facility for treatment, telehealth for OTVs would not
reduce the logistical burden placed on a patient.
Furthermore, we believe that weekly in-person assessments of patients, including a physical examination and
vital signs, are necessary to provide optimal care during
treatment. These visits allow us to assess tolerability of
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the prescribed treatment and to identify symptoms that, if
not managed appropriately, may result in an emergency
department visit or hospital admission. Preventing
avoidable hospital and emergency department usage has
been of utmost importance to us during the acute phase of
the pandemic when our hospital system had limited capacity to manage non-COVID patients.3 We do recognize
that in extreme situations in which physician shortages
may arise, a reverse telehealth model could be considered.
In this scenario, the patient can be seen and examined by a
midlevel provider in the clinic before being connected to
the physician remotely via a telehealth platform.

Beneﬁts and challenges of telehealth as part of
routine care
Since the implementation of our telehealth program,
we have observed unanticipated beneﬁts. For example, we
have seen more multidisciplinary consultation and followup appointments. Before COVID-19, our institution was
actively establishing multidisciplinary clinics, although
the logistics of such visits have historically been
complicated. Since the implementation of telehealth,
providers believe that telehealth has made it easier to
coordinate multidisciplinary visits with other providers
because these visits do not require the providers to be
physically present at the same location at a given time. An
additional beneﬁt providers have reported is the unique
perspective they gain by seeing a patient in their home
environment, often surrounded by family members who
otherwise would have been unable to accompany the
patient to the consult. Telehealth has provided an opportunity for providers to better understand the challenges
patients may encounter in their home environment.
We have also identiﬁed potential challenges, most
notably ensuring that patients have access to the same
ancillary services and educational materials that they have
with an in-person consultation. It will be important for
departments to identify opportunities to bridge this gap.
We are working on integrating our social workers, nutritionists, and patient navigators to our telehealth platform so they can participate in the consult. In addition, we
are working on digitizing our educational material, which
we plan to share with patients on-screen during the consult and make available for access digitally after the
clinical encounter.
Another challenge of telehealth is ensuring that
patient-clinician communication is not negatively
affected. Essential components of effective communication include nonverbal cues, providing adequate time for
patient questions, and the ability to build rapport and
demonstrate empathy. Studies have emphasized the
importance of maintaining effective communication and
actively engaging patients during video conferencing.21-23
However, the majority of clinicians are not trained in
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effectively conducting a telehealth visit, and some may
have more difﬁculty with the transition. Institutions that
plan to adopt telehealth should make training programs
and resources available for clinicians to sharpen their
communication skills over telehealth.

Conclusions
Telehealth has been an imminent disruptive innovation in health care for many years, and few could have
anticipated the velocity at which it has been implemented
during the COVID-19 pandemic. Our experience has
shown that telehealth has many potential beneﬁts if used
thoughtfully and systematically. Our department intends
to use telehealth broadly, and we have created guidelines
for our physicians to use when scheduling visits. At the
same time, we understand the limitations and challenges
of telehealth and have outlined when telehealth should
not be used. The impact of this new approach must be
studied, and we propose quality metrics to measure the
outcomes of these interventions carefully. The largescale adoption of telehealth nationally will generate
much-needed experience, which will help guide us
moving forward. We must carefully examine the data
gathered and lessons learned during this unprecedented
time. We believe that the appropriate use of telehealth
can improve access and outcomes and complement the
existing clinic-centered model of care. As health care
providers, we must adapt to and continually improve the
use of telehealth, with the ultimate goal of providing
patient-centered, feasible, and effective care for all patients with cancer.

Supplementary Materials
Supplementary material for this article can be found at
https://doi.org/10.1016/j.adro.2020.09.015.
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